The combination of SAHA with ATRA, 9-cis RA, troglitazone, or thyroid hormone T3 did not enhance the expression of NIS compared with SAHA alone in BHP papillary thyroid carcinoma cells (sublines 2–7 and 10–3). Here, SLC5A5 is linked to thyroid gland papillary carcinoma.